Medicare Enrolled
Dr. Marco Araneda, M.D.
Medical Oncology · Harlingen, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Araneda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Araneda? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Araneda
Dr. Marco Araneda is a medical oncology in Harlingen, TX, with 19 years in practice. Based on federal Medicare data, Dr. Araneda performed 53,762 Medicare services across 2,531 unique beneficiaries.
Between the years covered by Open Payments, Dr. Araneda received a total of $4,751 from 58 pharmaceutical and/or device companies across 194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Araneda is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 20% volume in TX$ $4,751 industry payments
Medicare Practice Summary
Medicare Utilization ↗53,762
Medicare services
Top 20% in TX for medical oncology
2,531
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,830 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 25,300 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 8,805 | $2 | $20 |
| Denosumab injection (Prolia/Xgeva) | 4,800 | $18 | $66 |
| Contrast dye for imaging (iodine-based) | 3,200 | $0 | $3 |
| Dexamethasone injection (steroid) | 2,045 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia | 1,620 | $6 | $28 |
| Injection, granisetron hydrochloride, 100 mcg | 790 | $0 | $24 |
| Complete blood count (CBC) with differential | 722 | $8 | $36 |
| Injection, leucovorin calcium, per 50 mg | 700 | $3 | $25 |
| Office visit, established patient (30-39 min) | 595 | $89 | $368 |
| Blood draw (venipuncture) | 582 | $8 | $20 |
| Comprehensive metabolic blood panel | 559 | $10 | $64 |
| Injection, fluorouracil, 500 mg | 519 | $2 | $13 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 320 | $22 | $157 |
| Anti-nausea injection (Aloxi/palonosetron) | 280 | $1 | $114 |
| Administration of chemotherapy into vein, 1 hour or less | 221 | $98 | $707 |
| Drug injection, under skin or into muscle | 215 | $10 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 183 | $46 | $313 |
| Ferritin level test (iron stores) | 181 | $13 | $60 |
| Iron level test | 181 | $6 | $27 |
| Iron binding capacity test | 181 | $9 | $35 |
| Lactate dehydrogenase (enzyme) level | 165 | $6 | $31 |
| Hospital follow-up visit, high complexity | 146 | $90 | $357 |
| Injection, zoledronic acid, 1 mg | 129 | $6 | $431 |
| Magnesium level test | 117 | $7 | $29 |
| Red blood count automated, with additional calculations | 111 | $5 | $26 |
| Reticulated (young) platelet measurement | 90 | $35 | $143 |
| Administration of chemotherapy into vein, each additional hour | 83 | $21 | $161 |
| Administration of additional new drug or substance into vein, 1 hour or less | 81 | $49 | $344 |
| Injection, diphenhydramine hcl, up to 50 mg | 77 | $1 | $7 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 71 | $53 | $211 |
| Microscopic examination for white blood cells with manual cell count | 53 | $4 | $22 |
| Complete blood count (CBC), automated | 53 | $6 | $34 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 51 | $347 | $1,722 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 50 | $124 | $500 |
| Basic metabolic blood panel | 49 | $8 | $49 |
| Irrigation of implanted venous access drug delivery device | 49 | $18 | $114 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 48 | $24 | $145 |
| New patient office visit (45-59 min) | 48 | $117 | $565 |
| Injection, ketorolac tromethamine, per 15 mg | 46 | $0 | $4 |
| Administration of additional new drug or substance into vein using push technique | 39 | $42 | $289 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 38 | $15 | $100 |
| Injection of additional new drug or substance into vein | 36 | $12 | $108 |
| Ct scan of chest with contrast | 28 | $52 | $821 |
| Initial hospital admission, high complexity | 26 | $130 | $694 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 21 | $15 | $94 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 21 | $92 | $657 |
| CT scan of abdomen and pelvis with contrast | 20 | $160 | $1,067 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 17 | $1,109 | $4,802 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
91.3% medium
7.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,751
Total received (2018-2024)
Avg $679/year across 7 years
Top 48% in TX for medical oncology
58
Companies
194
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,079 (85.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$672 (14.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,129
2023$1,322
2022$1,064
2021$201
2020$218
2019$640
2018$176
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$516
Eisai Inc.
$288
Novartis Pharmaceuticals Corporation
$260
Seagen Inc.
$255
Amgen Inc.
$229
PFIZER INC.
$218
Merck Sharp & Dohme LLC
$197
Genentech USA, Inc.
$174
Astellas Pharma US Inc
$159
E.R. Squibb & Sons, L.L.C.
$155
Celgene Corporation
$141
Lilly USA, LLC
$118
AstraZeneca Pharmaceuticals LP
$109
Janssen Pharmaceuticals, Inc
$104
EISAI INC.
$99
Allergan Inc.
$96
GlaxoSmithKline, LLC.
$91
Smith+Nephew, Inc.
$86
AVEO Pharmaceuticals, Inc.
$85
Merck Sharp & Dohme Corporation
$85
Daiichi Sankyo Inc.
$81
GENZYME CORPORATION
$78
BeiGene USA, Inc.
$75
Bayer Healthcare Pharmaceuticals Inc.
$66
Boston Scientific Corporation
$56
Exelixis Inc.
$55
Ipsen Biopharmaceuticals, Inc
$55
Kite Pharma, Inc.
$53
ADC Therapeutics America, Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$45
Deciphera Pharmaceuticals Inc.
$45
ABBVIE INC.
$42
PUMA BIOTECHNOLOGY, INC.
$40
Bayer HealthCare Pharmaceuticals Inc.
$38
Kyowa Kirin, Inc.
$37
Foundation Medicine, Inc.
$36
Regeneron Healthcare Solutions, Inc.
$31
MorphoSys, US Inc.
$31
Gilead Sciences, Inc.
$29
Blue Earth Diagnostics Limited
$29
Genmab U.S., Inc.
$29
JAZZ PHARMACEUTICALS INC.
$28
Karyopharm Therapeutics Inc.
$26
Mirati Therapeutics, Inc.
$21
Teva Pharmaceuticals USA, Inc.
$21
TerSera Therapeutics LLC
$19
Melinta Therapeutics, LLC
$16
Agios Pharmaceuticals, Inc.
$16
PharmaEssentia USA Corporation
$16
Tolmar, Inc.
$16
Puma Biotechnology, Inc.
$16
Telix Pharmaceuticals
$16
TAIHO ONCOLOGY, INC.
$15
Sobi, Inc
$15
Sumitomo Pharma America, Inc.
$14
Epizyme, Inc.,
$13
Seattle Genetics, Inc.
$12
EMD Serono, Inc.
$12
Top 3 companies account for 22.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · AVYCAZ · Alecensa · Axumin · BENDEKA · BESREMI · BRUKINSA · Bavencio · CABOMETYX · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · ELIGARD · ELIQUIS · ELITEK · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · Fabhalta · GAZYVA · GRAFIX PL · Gazyva · IBRANCE · ILLUCCIX · IMFINZI · INLYTA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · Lenvima · Leqembi · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · PADCEV · PIQRAY · POTELIGEO · PROMACTA · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · Rezzayo · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Somatuline Depot · Stivarga · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · VENCLEXTA · VERZENIO · VPRIV · Vectibix · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xospata · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
5
Per 100K population
1.2
County median income
$51,334
Nearest hospital
VHS HARLINGEN HOSPITAL COMPANY LLC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Araneda is a mixed practice specialist, with above-average Medicare volume (top 20% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Araneda experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Araneda performed 25,300 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Araneda receive payments from pharmaceutical companies?
Yes. Dr. Araneda received a total of $4,751 from 58 companies across 194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Araneda's costs compare to other medical oncologys in Harlingen?
Dr. Araneda's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Araneda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Harlingen
Browse medical oncologys in Harlingen ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in TX
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in TX
Which TX medical oncologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology